flag flag  

author = "Taher, Ali"

Found 27 documents, displaying page 2 of 3

Non-Hodgkin's lymphoma in a woman with adult-onset Still's disease: a case report

Description :

Abstract

Introduction

Adult onset Still's disease is a chronic multisystemic inflammatory disorder characterized by high spiking fever, polyarthralgia and rash. Lymphadenopathy is a prominent feature of adult onset Still's disease and is seen in about 65% of patients. Searching the ...

Repository : DOAJ-Articles
Language(s) : English

Coagulopathy in Beta-Thalassemia: Current Understanding and Future Perspectives

Description : As the life expectancy of β-thalassemia patients has markedly improved over the last decade, several new complications are being recognized. The presence of a high incidence of thromboembolic events, mainly in thalassemia intermedia patients, has led to the identification of a hypercoagulable state ...
Repository : Europe PubMed Central
Language(s) : English

Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia

Description : This subgroup analysis evaluated the effect of once-daily oral deferasirox on labile plasma iron (LPI) levels in patients from the prospective, 1-yr, multicentre ESCALATOR study. Mean baseline liver iron concentration and median serum ferritin levels were 28.6 ± 10.3 mg Fe/g dry weight and 6334 ng/m...
Repository : Europe PubMed Central
Language(s) : English

Antithrombotic Prophylaxis in the Middle East

Description : Several factors have been proposed to explain the persistence of a high incidence of venous thromboembolism worldwide with its associated morbidity and mortality. Underutilization of anticoagulants and failure of adherence to thromboprophylaxis guidelines are emerging global health concerns. We here...
Repository : Europe PubMed Central
Language(s) : English

Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload

Description : The highest approved dose of deferasirox is currently 30 mg/kg per d in many countries; however, some patients require escalation above 30 mg/kg per d to achieve their therapeutic goals. This retrospective analysis investigated the efficacy (based on change in serum ferritin levels) and safety of de...
Repository : Europe PubMed Central
Language(s) : English

Found 27 documents, displaying page 2 of 3